190 related articles for article (PubMed ID: 36232847)
1. REMD Simulations of Full-Length Alpha-Synuclein Together with Ligands Reveal Binding Region and Effect on Amyloid Conversion.
Semenyuk PI
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232847
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein.
Semenyuk PI
Biophys Chem; 2024 Apr; 307():107196. PubMed ID: 38335809
[TBL] [Abstract][Full Text] [Related]
3. Epitope region identification challenges of intrinsically disordered proteins in neurodegenerative diseases: Secondary structure dependence of α-synuclein on simulation techniques and force field parameters.
Mandaci SY; Caliskan M; Sariaslan MF; Uversky VN; Coskuner-Weber O
Chem Biol Drug Des; 2020 Jul; 96(1):659-667. PubMed ID: 31903719
[TBL] [Abstract][Full Text] [Related]
4. Cross-Linked α-Synuclein as Inhibitor of Amyloid Formation.
Murvai N; Gellen G; Micsonai A; Schlosser G; Kardos J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686208
[TBL] [Abstract][Full Text] [Related]
5. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation.
Bhasne K; Mukhopadhyay S
Proteomics; 2018 Nov; 18(21-22):e1800059. PubMed ID: 30216674
[TBL] [Abstract][Full Text] [Related]
6. Structures of the intrinsically disordered Aβ, tau and α-synuclein proteins in aqueous solution from computer simulations.
Nguyen PH; Derreumaux P
Biophys Chem; 2020 Sep; 264():106421. PubMed ID: 32623047
[TBL] [Abstract][Full Text] [Related]
7. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein.
Lee EN; Cho HJ; Lee CH; Lee D; Chung KC; Paik SR
Biochemistry; 2004 Mar; 43(12):3704-15. PubMed ID: 15035641
[TBL] [Abstract][Full Text] [Related]
8. Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein.
Williams JK; Yang X; Baum J
Proteomics; 2018 Nov; 18(21-22):e1800109. PubMed ID: 30142698
[TBL] [Abstract][Full Text] [Related]
9. Role of Tyr-39 for the Structural Features of α-Synuclein and for the Interaction with a Strong Modulator of Its Amyloid Assembly.
Palomino-Hernandez O; Buratti FA; Sacco PS; Rossetti G; Carloni P; Fernandez CO
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709107
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring cinnamic acid derivatives prevent amyloid transformation of alpha-synuclein.
Medvedeva M; Barinova K; Melnikova A; Semenyuk P; Kolmogorov V; Gorelkin P; Erofeev A; Muronetz V
Biochimie; 2020 Mar; 170():128-139. PubMed ID: 31945397
[TBL] [Abstract][Full Text] [Related]
11. Lipid-Chaperone Hypothesis: A Common Molecular Mechanism of Membrane Disruption by Intrinsically Disordered Proteins.
Sciacca MF; Lolicato F; Tempra C; Scollo F; Sahoo BR; Watson MD; García-Viñuales S; Milardi D; Raudino A; Lee JC; Ramamoorthy A; La Rosa C
ACS Chem Neurosci; 2020 Dec; 11(24):4336-4350. PubMed ID: 33269918
[TBL] [Abstract][Full Text] [Related]
12. Molecular Basis of Small-Molecule Binding to α-Synuclein.
Robustelli P; Ibanez-de-Opakua A; Campbell-Bezat C; Giordanetto F; Becker S; Zweckstetter M; Pan AC; Shaw DE
J Am Chem Soc; 2022 Feb; 144(6):2501-2510. PubMed ID: 35130691
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
[TBL] [Abstract][Full Text] [Related]
14. Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.
Tóth G; Gardai SJ; Zago W; Bertoncini CW; Cremades N; Roy SL; Tambe MA; Rochet JC; Galvagnion C; Skibinski G; Finkbeiner S; Bova M; Regnstrom K; Chiou SS; Johnston J; Callaway K; Anderson JP; Jobling MF; Buell AK; Yednock TA; Knowles TP; Vendruscolo M; Christodoulou J; Dobson CM; Schenk D; McConlogue L
PLoS One; 2014; 9(2):e87133. PubMed ID: 24551051
[TBL] [Abstract][Full Text] [Related]
15. Increased Aggregation Tendency of Alpha-Synuclein in a Fully Disordered Protein Complex.
Merle DA; Witternigg A; Tam-Amersdorfer C; Hartlmüller C; Spreitzer E; Schrank E; Wagner-Lichtenegger S; Werzer O; Zangger K; Kungl AJ; Madl T; Meyer NH; Falsone SF
J Mol Biol; 2019 Jun; 431(14):2581-2598. PubMed ID: 31034892
[TBL] [Abstract][Full Text] [Related]
16. Effect of Osmolytes on Conformational Behavior of Intrinsically Disordered Protein α-Synuclein.
Jahan I; Nayeem SM
Biophys J; 2019 Nov; 117(10):1922-1934. PubMed ID: 31699336
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
Werner T; Horvath I; Wittung-Stafshede P
J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
[TBL] [Abstract][Full Text] [Related]
18. Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches.
Vidović M; Rikalovic MG
Cells; 2022 May; 11(11):. PubMed ID: 35681426
[TBL] [Abstract][Full Text] [Related]
19. Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations.
Wu KP; Weinstock DS; Narayanan C; Levy RM; Baum J
J Mol Biol; 2009 Aug; 391(4):784-96. PubMed ID: 19576220
[TBL] [Abstract][Full Text] [Related]
20. Molecular Insights into the Misfolding and Dimerization Dynamics of the Full-Length α-Synuclein from Atomistic Discrete Molecular Dynamics Simulations.
Zhang Y; Wang Y; Liu Y; Wei G; Ding F; Sun Y
ACS Chem Neurosci; 2022 Nov; 13(21):3126-3137. PubMed ID: 36278939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
